Compare GALT & CMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GALT | CMRC |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | United States | United States |
| Employees | N/A | 1079 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | 227.7M |
| IPO Year | 2008 | N/A |
| Metric | GALT | CMRC |
|---|---|---|
| Price | $2.53 | $3.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $8.50 | $4.88 |
| AVG Volume (30 Days) | 348.5K | ★ 873.2K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.11 |
| Revenue Next Year | N/A | $4.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.27 | $2.41 |
| 52 Week High | $7.13 | $5.55 |
| Indicator | GALT | CMRC |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 57.50 |
| Support Level | $2.09 | $2.69 |
| Resistance Level | $2.60 | $3.45 |
| Average True Range (ATR) | 0.23 | 0.17 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 44.71 | 84.40 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Commerce.com Inc is engaged in offering a Software-as-a-Service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which the majority of its revenue is generated from Americas-U.S.